1Life Healthcare, Inc.
ONEM · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.60 | -0.40 | -1.91 | 0.98 |
| FCF Yield | -1.49% | -2.55% | -4.90% | -3.47% |
| EV / EBITDA | -44.66 | -41.71 | -26.29 | -35.28 |
| Quality | ||||
| ROIC | -4.34% | -4.85% | -3.83% | -3.57% |
| Gross Margin | 17.55% | 18.56% | 15.63% | 18.80% |
| Cash Conversion Ratio | 0.32 | 0.58 | 0.64 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 40.10% | 43.86% | 43.08% | 37.21% |
| Free Cash Flow Growth | 40.25% | -14.26% | -0.60% | 20.06% |
| Safety | ||||
| Net Debt / EBITDA | -5.01 | -5.46 | -6.03 | -5.40 |
| Interest Coverage | -37.73 | -164.12 | -26.36 | -18.06 |
| Efficiency | ||||
| Inventory Turnover | 28.46 | 27.39 | 32.85 | 34.27 |
| Cash Conversion Cycle | 42.21 | 58.80 | 49.51 | 46.11 |